Chinese Medicine Combined with Adjuvant Chemotherapy for Improving Myelosuppression in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis

被引:2
作者
Li, Rui [1 ]
Zhang, Tong [1 ]
Yan, Shao-hua [2 ]
Yan, Yun-zi [3 ]
Ding, Ya-cong [1 ]
Wang, Yan-song [3 ]
Yang, Yu-fei [1 ]
机构
[1] Xiyuan Hosp, China Acad Chinese Med Sci, Dept Oncol, Beijing 100091, Peoples R China
[2] Beijing Univ Chinese Med, Dept Oncol, Dongfang Hosp, Beijing 100078, Peoples R China
[3] Beijing Univ Chinese Med, Grad Sch, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
Chinese herbal medicine; colorectal cancer; network meta-analysis; systematic review; myelosuppression; chemotherapy; III COLON-CANCER; OXALIPLATIN; FLUOROURACIL; NEUTROPENIA; MULTICENTER; LEUCOVORIN; ANEMIA; TRENDS;
D O I
10.1007/s11655-023-3558-7
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
ObjectiveTo assess the effectiveness of Chinese herbal medicine (CHM) combined with adjuvant chemotherapy on myelosuppression for colorectal cancer (CRC) patients using network meta-analysis (NMA).MethodsLiterature searches in both international (PubMed, Embase, Web of Science, and Cochrane Library) and Chinese (China Science and Technology Journal Database, Wanfang Data, China National Knowledge Infrastructure) databases for relevant randomized controlled trials (RCTs) were conducted from inception until October 10, 2022. We included RCTs of patients who received CHM combined with chemotherapy, including FOLFOX, XELOX, FOLFIRI, and other relevant regimens in the CHM treatment group. The outcomes included the incidence of myelosuppression, leukopenia, hemoglobin reduction, and thrombocytopenia. Two reviewers independently screened the databases, extracted the data, and assessed the risk of bias and credibility of evidence. RevMan 5.4.1 software and STATA 14.0 were used to perform the NMA.ResultsA total of 31 RCTs were included, published from 2008 to 2021 in Chinese. Among these, 2,314 participants comparing the following 9 CHMs were identified: Shengbai Recipe (SBR), Bazhen Decoction (BZD), Jianpi Jiedu Recipe (JJR), Jianpi Recipe (JR), Compound Cantharis Capsule (CCC), Zaofan Pill (ZFP), Guilu Erxian Gel (GL), Buzhong Tiaogan Decoction (BZ), and Qiamagu Capsule (QM). The results of NMA found an indirect comparison. Based on the surface under the cumulative ranking curve (SUCRA), the ZFP+ chemotherapy group had the lowest incidence of myelosuppression, with an odds ratio (OR) of 0.08 [95% confidence interval (CI): 0.01, 0.76], whereas the GL+ chemotherapy group had the lowest incidence of leukopenia, hemoglobin reduction, and thrombocytopenia, with an OR of 5.25 (95% CI: 2.41, 11.43), 4.66 (95% CI: 2.23, 9.72), and 0.27 (95% CI: 0.13, 0.54), respectively. Moreover, BZD + chemotherapy could alleviate leukopenia, hemoglobin reduction, and thrombocytopenia (P<0.01). Pairwise comparison showed that there was no difference in the efficacy among the 8 CHMs+ chemotherapy group. The comparison and adjustment funnel plot indicated that small-study effect had no impact on these outcomes.ConclusionsThis NMA provided evidence to support that patients with CRC benefit from receiving different combination of CHM chemotherapies. Among these, GL plus chemotherapy and BZD plus chemotherapy were the more effective for myelosuppression in patients; however, as the qualtiy of evidence is insufficient, further research is needed.
引用
收藏
页码:643 / 652
页数:10
相关论文
共 48 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[2]  
[Anonymous], 2007, Liaoning J Tradit Chin Med (Chin)
[3]   The Association of Preoperative Anemia and the Postoperative Course and Oncological Outcome in Patients Undergoing Rectal Cancer Surgery: A Multicenter Snapshot Study [J].
Bruns, Emma R. J. ;
Borstlap, Wernard A. ;
van Duijvendijk, Peter ;
van der Zaag-Loonen, Hester J. ;
Buskens, Christianne J. ;
van Munster, Barbara C. ;
Bemelman, Willem A. ;
Tanis, Pieter J. .
DISEASES OF THE COLON & RECTUM, 2019, 62 (07) :823-831
[4]  
Chen J., 2021, BEIJING J TRADIT CHI, V40, P747
[5]   Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer [J].
Chen, Jinbao ;
Wu, Wentao ;
He, Xue ;
Jia, Linlin ;
Yang, Jiahua ;
Si, Xianke ;
Yu, Kun ;
Li, Sen ;
Qiu, Yanyan ;
Xu, Ke ;
Yin, Peihao ;
Cao, Yijun ;
Li, Qiong ;
Li, Wei .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :8329-8339
[6]   REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER [J].
CRAWFORD, J ;
OZER, H ;
STOLLER, R ;
JOHNSON, D ;
LYMAN, G ;
TABBARA, I ;
KRIS, M ;
GROUS, J ;
PICOZZI, V ;
RAUSCH, G ;
SMITH, R ;
GRADISHAR, W ;
YAHANDA, A ;
VINCENT, M ;
STEWART, M ;
GLASPY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :164-170
[7]   Cellular and molecular aspects of drugs of the future: oxaliplatin [J].
Di Francesco, AM ;
Ruggiero, A ;
Riccardi, R .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (11) :1914-1927
[8]  
Dong Y., 2018, J SICHUAN TRAD CHIN, V36, P91
[9]   Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life [J].
Epstein, Robert S. ;
Roy, Upal K. Basu ;
Aapro, Matti ;
Salimi, Tehseen ;
Moran, Donald ;
Krenitsky, JoAnn ;
Leone-Perkins, Megan L. ;
Girman, Cynthia ;
Schlusser, Courtney ;
Crawford, Jeffrey .
PATIENT PREFERENCE AND ADHERENCE, 2021, 15 :453-465
[10]   Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines [J].
Falandry, C. ;
Campone, M. ;
Cartron, G. ;
Guerin, D. ;
Freyer, G. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (13) :2389-2398